Elevated Level of Troponin but Not N-Terminal Probrain Natriuretic Peptide Is Associated with Increased Risk of Sudden Cardiac Death in Hypertrophic Cardiomyopathy Calculated According to the ESC Guidelines 2014

Table 2

Comparison between subgroups of hs-TnI positive versus negative and also between subgroup of lower versus higher NT-proBNT concentration (NS: nonsignificant).

First model—current Holter
	Hs-TnI negative	Hs-TnI positive
5-year SCD risk in HCM	3.81 ± 3.23%	6.38 ± 4.17%
	Lower NT-proBNP	Higher NT-proBNP
5-year SCD risk in HCM	4.14 ± 4.18%	5.18 ± 3.63%	NS
Second model—all Holter
	Hs-TnI negative	Hs-TnI positive
5-year SCD risk in HCM	4.25 ± 4.20%	6.90 ± 3.99%
	Lower NT-proBNP	Higher NT-proBNP
5-year SCD risk in HCM	4.40 ± 3.62%	6.29 ± 4.18%	NS